Related Experiment Video
Updated: Jun 19, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Clinical Characteristics and Antimicrobial Resistance of Escherichia coli Bloodstream Infections in Neonates: A
Caifang Ma1, Zhenjia Liu2, Linlin Li1
1Department of Clinical Laboratory, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Insights
Escherichia coli bloodstream infections (BSIs) in neonates differ from older children. Low albumin, total bile acid, and high direct bilirubin predict ICU admission risk in newborns with E. coli BSIs.
Area of Science:
- Infectious Diseases
- Neonatal Medicine
- Clinical Microbiology
Background:
- Escherichia coli (E. coli) bloodstream infections (BSIs) pose a significant global health challenge, particularly in vulnerable neonatal populations.
- Understanding the unique clinical and microbiological aspects of E. coli BSIs in neonates is crucial for effective management and improved patient outcomes.
Purpose of the Study:
- To investigate the clinical characteristics, laboratory indicators, treatment outcomes, and antimicrobial resistance patterns of E. coli BSIs in neonates.
- To identify specific laboratory markers that predict the need for intensive care unit (ICU) admission in neonates with E. coli BSIs.
Main Methods:
- A retrospective analysis of 179 patients with E. coli BSIs (91 neonates, 88 non-neonates) from January 2017 to December 2023.
- Comparison of clinical parameters, laboratory results, and antimicrobial susceptibility between neonatal and non-neonatal groups.
- Multivariable regression and ROC curve analysis to identify predictors of ICU admission in neonates.
Main Results:
- Neonates with E. coli BSIs showed distinct resistance patterns, with high rates against ampicillin (83.52%), sulfamethoxazole (51.65%), and cefazolin (46.15%).
- Non-neonates exhibited higher resistance to ceftazidime, imipenem, and meropenem compared to neonates.
- Decreased albumin (ALB) and total bile acid (TBA), along with increased direct bilirubin (DBIL), were identified as independent risk factors for ICU admission in neonates.
Conclusions:
- E. coli BSIs present unique clinical and resistance profiles in neonates versus older children.
- Specific laboratory markers—low ALB (<33.06 g/L), low TBA (<8.2 μmol/L), and high DBIL (>14.64 μmol/L)—are significant predictors of ICU admission in neonates.
- Monitoring these biomarkers can aid in early identification and management of high-risk neonates with E. coli BSIs, potentially improving outcomes.
Background:
Escherichia coli (E. coli) bloodstream infections (BSIs) are a significant public health concern. This study aimed to examine the clinical characteristics, laboratory indicators, outcomes, and antimicrobial resistance patterns of E. coli BSIs in neonatal populations.
Materials And Methods:
A retrospective analysis was conducted from January 2017 to December 2023 at Guangxi Children's Hospital in China. We compared neonatal and non-neonatal patient groups, analyzing clinical parameters, lab results, and antimicrobial susceptibility patterns. Using multivariable regression analysis, we identified specific laboratory markers as prognostic indicators for ICU admission in newborns with E. coli BSIs. Diagnostic efficacy was assessed using ROC curves, sensitivity, and specificity.
Results:
The study analyzed 179 hospitalized patients with E. coli BSIs, including 91 neonates (0-28 days) and 88 older pediatric cases. Among the neonates, 52 (57%) required ICU admission, while the remaining 39 (43%) were managed in general pediatric wards. In neonates, the highest resistance rate was observed for ampicillin (83.52%), followed by sulfamethoxazole (51.65%) and cefazolin (46.15%). Non-neonates exhibited higher resistance to ceftazidime (P=0.022), imipenem (P=0.021), meropenem (P=0.023), and other antibiotics. Multivariate analysis showed that decreased albumin (ALB) and total bile acid (TBA) levels, along with increased direct bilirubin (DBIL), were independent risk factors for ICU admission. Findings indicated that when ALB <33.06 g/L, TBA <8.2 μmol/L, and DBIL >14.64 μmol/L, the risk of ICU admission for neonates increased.
Conclusion:
E. coli BSIs in neonates and non-neonates exhibit distinct clinical features and resistance profiles. Low ALB and TBA, and high DBIL were found to be important predictors of ICU admission in neonates. Close monitoring of these markers can improve outcomes for high-risk neonates with E. coli BSIs.
Related Concept Videos
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test

